Avacta Group Plc (FRA:RTQ1)
0.8600
-0.0100 (-1.15%)
At close: Nov 24, 2025
Avacta Group Revenue
Avacta Group had revenue of 56.00K GBP in the half year ending June 30, 2025, a decrease of -99.53%. This brings the company's revenue in the last twelve months to 113.00K. In the year 2024, Avacta Group had annual revenue of 113.00K, down -96.04%.
Revenue
113.00K GBP
Revenue Growth
-96.04%
P/S Ratio
3,085.64
Revenue / Employee
748.34 GBP
Employees
151
Market Cap
406.77M EUR
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 113.00K | -2.74M | -96.04% |
| Dec 31, 2023 | 2.85M | -6.80M | -70.47% |
| Dec 31, 2022 | 9.65M | 6.71M | 228.22% |
| Dec 31, 2021 | 2.94M | 797.00K | 37.17% |
| Dec 31, 2020 | 2.14M | -1.75M | -44.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
Avacta Group News
- 27 days ago - Full Year 2024 Avacta Group PLC Live Presentation Transcript - GuruFocus
- 5 weeks ago - Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets - Wallstreet:Online
- 6 weeks ago - Avacta (AIM) Reports Promising Results in Faridoxorubicin Clinical Trial - GuruFocus
- 2 months ago - Avacta Group Plc (AVCTF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Avacta Group Plc (AVCTF) Preliminary Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 8 months ago - Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives - GlobeNewsWire
- 1 year ago - Avacta Group Plc (AVCTF) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors - GlobeNewsWire